HAEMOLYTIC URAEMIC SYNDROME

This adverse event was reported 2320 times

These drugs are most commonly taken by patients reporting HAEMOLYTIC URAEMIC SYNDROME:

# Drug Count
0 TACROLIMUS 346
1 TACROLIMUS EXTENDED-RELEASE CAPSULES 284
2 TACROLIMUS OINTMENT 0.1% 284
3 MYCOPHENOLATE MOFETIL HYDROCHLORIDE 250
4 MYCOPHENOLATE MOFETIL 249
5 GEMCITABINE HYDROCHLORIDE 239
6 ECULIZUMAB 202
7 GEMCITABINE 185
8 PREDNISONE 174
9 PREDNISOLONE 150
See all common drugs associated with HAEMOLYTIC URAEMIC SYNDROME

HAEMOLYTIC URAEMIC SYNDROME is most prevalent among patients taking these drugs:

# Drug Count Frequency
0 AESCULUS HIPPOCASTANUM WHOLE 4 0.0533
1 AGRIMONIA EUPATORIA 4 0.0526
2 CENTAURIUM ERYTHRAEA 4 0.0519
3 MITOMYCIN 24 0.0066
4 BELATACEPT 29 0.0061
5 BASILIXIMAB 69 0.0058
6 ANTI-THYMOCYTE GLOBULIN (RABBIT) 45 0.0055
7 CORTISOL 2 0.0050
8 PENTOSTATIN 5 0.0048
9 GEMCITABINE HYDROCHLORIDE 239 0.0044
See all drugs enriched for association with HAEMOLYTIC URAEMIC SYNDROME